Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells

FC-2.15 is a murine IgM monoclonal antibody (mAb) that recognizes a cell-surface antigen (Ag2.15) expressed in most tumor-proliferating cells of human breast carcinomas and other neoplasias. In this study the cytotoxic ability of mAb FC-2.15, its cell-surface binding properties and endocytosis in Ag...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ballaré, Cecilia J., Barrio, María Marcela, Portela, Paula
Publicado: 1995
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03407004_v41_n1_p15_Ballare
http://hdl.handle.net/20.500.12110/paper_03407004_v41_n1_p15_Ballare
Aporte de:
id paper:paper_03407004_v41_n1_p15_Ballare
record_format dspace
spelling paper:paper_03407004_v41_n1_p15_Ballare2023-06-08T15:34:08Z Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells Ballaré, Cecilia J. Barrio, María Marcela Portela, Paula Breast cancer Complement Cytotoxicity Monoclonal antibody (mAb) monoclonal antibody monoclonal antibody fc 2 15 unclassified drug article breast cancer cancer cell culture controlled study cytotoxicity female human human cell priority journal Antibodies, Monoclonal Antibody-Dependent Cell Cytotoxicity Antigen-Antibody Complex Antigens, Neoplasm Breast Neoplasms Complement Complement Activation Cytotoxicity, Immunologic Endocytosis Human In Vitro Support, Non-U.S. Gov't Tumor Cells, Cultured FC-2.15 is a murine IgM monoclonal antibody (mAb) that recognizes a cell-surface antigen (Ag2.15) expressed in most tumor-proliferating cells of human breast carcinomas and other neoplasias. In this study the cytotoxic ability of mAb FC-2.15, its cell-surface binding properties and endocytosis in Ag2.15-expressing (Ag2.15+) cells were investigated. A51Cr-release assay was used to test the FC-2.15-mediated cytotoxicity. When human serum was used as source of complement, FC-2.15 exerted a strong cytotoxic effect against human Ag2.15+ cells such as MCF-7 (breast cancer cell line), primary breast carcinoma cells, polymorphonuclear leukocytes and chronic myeloid leukemia cells. The mAb concentration range was 1-50 μg/ml. Cytotoxicity was completely abolished when complement was inactivated. Only 3.8±2.9% of MCF-7 cells survived the treatment with FC-2.15 in the presence of human serum. A flow-cytometry assay was performed to study the Ag2.15 expression of the surviving cells and they were found to be Ag2.15-. FC-2.15 did not mediate antibody-dependent cell cytotoxicity when different effector cells were used. Scatchard analysis with125I-FC-2.15 on MCF-7 cells demonstrated an affinity constant of 6.9×107 M-1 and 2.8×106 antigenic sites/cell.125I-FC-2.15 was internalized to cytoplasmic vesicles reaching a maximum of 27% after 6 h incubation, followed by the release of labeled degradation products to the supernatant. FC-2.15 appears to exert its cytotoxic effect mainly in the presence of human complement, it reacts with intermediate affinity with a high-density surface antigen, and it is slowly internalized by Ag2.15+ cells. © 1995 Springer-Verlag. Fil:Ballaré, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Barrio, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Portela, P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 1995 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03407004_v41_n1_p15_Ballare http://hdl.handle.net/20.500.12110/paper_03407004_v41_n1_p15_Ballare
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Breast cancer
Complement
Cytotoxicity
Monoclonal antibody (mAb)
monoclonal antibody
monoclonal antibody fc 2 15
unclassified drug
article
breast cancer
cancer cell culture
controlled study
cytotoxicity
female
human
human cell
priority journal
Antibodies, Monoclonal
Antibody-Dependent Cell Cytotoxicity
Antigen-Antibody Complex
Antigens, Neoplasm
Breast Neoplasms
Complement
Complement Activation
Cytotoxicity, Immunologic
Endocytosis
Human
In Vitro
Support, Non-U.S. Gov't
Tumor Cells, Cultured
spellingShingle Breast cancer
Complement
Cytotoxicity
Monoclonal antibody (mAb)
monoclonal antibody
monoclonal antibody fc 2 15
unclassified drug
article
breast cancer
cancer cell culture
controlled study
cytotoxicity
female
human
human cell
priority journal
Antibodies, Monoclonal
Antibody-Dependent Cell Cytotoxicity
Antigen-Antibody Complex
Antigens, Neoplasm
Breast Neoplasms
Complement
Complement Activation
Cytotoxicity, Immunologic
Endocytosis
Human
In Vitro
Support, Non-U.S. Gov't
Tumor Cells, Cultured
Ballaré, Cecilia J.
Barrio, María Marcela
Portela, Paula
Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
topic_facet Breast cancer
Complement
Cytotoxicity
Monoclonal antibody (mAb)
monoclonal antibody
monoclonal antibody fc 2 15
unclassified drug
article
breast cancer
cancer cell culture
controlled study
cytotoxicity
female
human
human cell
priority journal
Antibodies, Monoclonal
Antibody-Dependent Cell Cytotoxicity
Antigen-Antibody Complex
Antigens, Neoplasm
Breast Neoplasms
Complement
Complement Activation
Cytotoxicity, Immunologic
Endocytosis
Human
In Vitro
Support, Non-U.S. Gov't
Tumor Cells, Cultured
description FC-2.15 is a murine IgM monoclonal antibody (mAb) that recognizes a cell-surface antigen (Ag2.15) expressed in most tumor-proliferating cells of human breast carcinomas and other neoplasias. In this study the cytotoxic ability of mAb FC-2.15, its cell-surface binding properties and endocytosis in Ag2.15-expressing (Ag2.15+) cells were investigated. A51Cr-release assay was used to test the FC-2.15-mediated cytotoxicity. When human serum was used as source of complement, FC-2.15 exerted a strong cytotoxic effect against human Ag2.15+ cells such as MCF-7 (breast cancer cell line), primary breast carcinoma cells, polymorphonuclear leukocytes and chronic myeloid leukemia cells. The mAb concentration range was 1-50 μg/ml. Cytotoxicity was completely abolished when complement was inactivated. Only 3.8±2.9% of MCF-7 cells survived the treatment with FC-2.15 in the presence of human serum. A flow-cytometry assay was performed to study the Ag2.15 expression of the surviving cells and they were found to be Ag2.15-. FC-2.15 did not mediate antibody-dependent cell cytotoxicity when different effector cells were used. Scatchard analysis with125I-FC-2.15 on MCF-7 cells demonstrated an affinity constant of 6.9×107 M-1 and 2.8×106 antigenic sites/cell.125I-FC-2.15 was internalized to cytoplasmic vesicles reaching a maximum of 27% after 6 h incubation, followed by the release of labeled degradation products to the supernatant. FC-2.15 appears to exert its cytotoxic effect mainly in the presence of human complement, it reacts with intermediate affinity with a high-density surface antigen, and it is slowly internalized by Ag2.15+ cells. © 1995 Springer-Verlag.
author Ballaré, Cecilia J.
Barrio, María Marcela
Portela, Paula
author_facet Ballaré, Cecilia J.
Barrio, María Marcela
Portela, Paula
author_sort Ballaré, Cecilia J.
title Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
title_short Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
title_full Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
title_fullStr Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
title_full_unstemmed Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
title_sort functional properties of fc-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
publishDate 1995
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03407004_v41_n1_p15_Ballare
http://hdl.handle.net/20.500.12110/paper_03407004_v41_n1_p15_Ballare
work_keys_str_mv AT ballarececiliaj functionalpropertiesoffc215amonoclonalantibodythatmediateshumancomplementcytotoxicityagainstbreastcancercells
AT barriomariamarcela functionalpropertiesoffc215amonoclonalantibodythatmediateshumancomplementcytotoxicityagainstbreastcancercells
AT portelapaula functionalpropertiesoffc215amonoclonalantibodythatmediateshumancomplementcytotoxicityagainstbreastcancercells
_version_ 1768546542308818944